findmyKOL

Shayan Shirazian, MD

Enriched profile

Associate Professor of Medicine, Division of Nephrology · Columbia University Irving Medical Center (CUIMC)

ORCIDNPI
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyNephrologyFocusChronic Kidney Disease+1
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Shayan Shirazian is Associate Professor of Medicine, Division of Nephrology at Columbia University Irving Medical Center (CUIMC). OpenAlex indexes 64 publications with 2,269 citations (h-index 20); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Shayan Shirazian, MD, is Associate Professor of Medicine, Division of Nephrology at Columbia University Irving Medical Center (CUIMC). The public record shows 64 publications with 2,269 citations (h-index 20), centered on Chronic Kidney Disease, ESRD / Dialysis. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 9 companies.

  • Most recent indexed publication: 2023 · PloS one
  • Top research focus: Chronic Kidney Disease
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 9 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
ESRD / Dialysis1 trialAlzheimer's / Dementia1 trialChronic Kidney Disease1 trialCognitive Dysfunction1 trialRenal Insufficiency, Chronic1 trialRenal Insufficiency1 trialHyperparathyroidism, Secondary1 trialHyperphosphatemia1 trialHyperparathyroidism1 trialHypercalcemia1 trial

Research focus

OpenAlex concept fingerprint
Chronic Kidney DiseaseESRD / Dialysis

Drugs & molecules

across trials, industry payments and publications
Veltassageneric · PatiromerClinical trialsIndustry payments2PublicationsJynarquegeneric · TolvaptanClinical trialsIndustry payments1PublicationsUltomirisgeneric · RavulizumabClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Otsuka Pharmaceutical Development & Commercialization, Inc.Clinical trialsIndustry payments17Vifor Pharma, Inc.Clinical trialsIndustry payments7Baxter HealthcareClinical trialsIndustry payments2

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
64publications

Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.

2,269citations

Total citations across indexed works.

20h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials
9companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    54.1%
    Angiotensin receptor blocker (ARB)13%
    Telmisartan56%Losartan Potassium44%
    Part D<11 patients
    Loop diuretic11.6%
    Torsemide100%
    Part D17 patients
  • Metabolism & gastrointestinal

    19.8%
    Metabolic Alkalinizer10.9%
    Potassium Citrate Er100%
    Part D20 patients
    Vitamin D3 Analog3.2%
    Calcitriol100%
    Part D<11 patients
  • Other

    13.4%
    Drugs for treatment of hyperkalemia and hyperphosphatemia7.5%
    Lokelma100%
    Part D<11 patients
    Phosphate Binder5.9%
    Sevelamer Carbonate100%
    Part D<11 patients
3 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)34.3% facility · 65.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/shayan-shirazian-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/shayan-shirazian-97a1b594

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/profile/Shayan-Shirazian

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Psychu.org

    Listed as team member (Assistant Professor of Medicine, Division of Nephrology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychu.org

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu
  • Internal Medicine residency

    Columbia University Medical Center / NewYork-Presbyterian Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.nyp.org
  • Nephrology fellowship

    Columbia University Medical Center / NewYork-Presbyterian Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.nyp.org
  • Board Certified

    Internal Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu
  • Board Certified

    Nephrology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • Panel interview participant

    NephU, "Future Of Healthcare" with Joshua Lipschutz, MD

    2021
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.